Literature DB >> 6234016

Reduced helper (OKT4+): suppressor (OKT8+) T ratios in aplastic anaemia: relation to immunosuppressive therapy.

K Kuriyama, M Tomonaga, I Jinnai, T Matsuo, Y Yoshida, T Amenomori, Y Yamada, M Ichimaru.   

Abstract

T cell subset composition of peripheral blood and bone marrow from 22 patients with aplastic anaemia (AA) was studied by monoclonal antibodies (OKT3, OKT4 and OKT8). In the peripheral blood, OKT3 (pan-T), OKT4 (helper/inducer-T) and OKT8 (suppressor-T) cells varied widely in number. The ratios of OKT4:OKT8 exhibited the same tendency. However, a subgroup of AA with a reduced ratio of lower than 1.0 was present both in cases with or without prior prednisolone therapy. Of the eight patients treated with immunosuppressants, four with reduced ratios responded, whereas the other four with normal or higher ratios did not. The ratios of two of four responders gradually reached the normal level. These results suggest that the reduced OKT4:OKT8 ratio may be related to the cell-mediated immunosuppressive mechanism postulated as a cause of stem cell inhibition in a subgroup of AA, and indicate prospectively the effectiveness of immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234016     DOI: 10.1111/j.1365-2141.1984.tb02902.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  T-lymphocyte subpopulations in the peripheral blood and bone marrow of patients with aplastic anemia.

Authors:  R P Falcão; J C Voltarelli; C Bottura
Journal:  Blut       Date:  1985-02

2.  Identification of activated T cells and the suppressor/inducer subset in patients suffering from severe aplastic anemia.

Authors:  U Köller; W Hinterberger; L Gschwandtler; R Grümayer; O Majdic; W Knapp
Journal:  Blut       Date:  1989-01

3.  Immune suppression therapy in aplastic anemia: influencing factors on response and survival.

Authors:  J Y Jin; D W Kim; J W Lee; C W Han; W S Min; C W Park; C C Kim; D J Kim; H K Kim; H H Song
Journal:  Korean J Intern Med       Date:  1995-01       Impact factor: 2.884

4.  Immunomodulation therapy for severe aplastic anemia--ALG versus ALG plus cyclosporin A.

Authors:  C W Park; C H Han; C C Kim; D J Kim; H K Kim
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884

5.  Very severe aplastic anemia appearing after thymectomy.

Authors:  Chi Young Park; Hee Je Kim; Yoo Jin Kim; Yoon Hee Park; Jong Wook Lee; Woo Sung Min; Chun Choo Kim
Journal:  Korean J Intern Med       Date:  2003-03       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.